Rare diseases get the spotlight on “Behind The Mystery – Rare and Genetic Diseases;” special episodes of The Balancing Act, which airs on Lifetime weekday mornings at 7AM.
The mission of “Behind the Mystery: Rare and Genetic Diseases” is to educate the public about rare and genetic diseases and treatments, and provide support through collaborations in education with pharmaceutical companies, foundations and patient advocacy groups. Partnering with the Global Genes Project, The Balancing Act is the only television show with a special of this kind, working to bring awareness to the plight of rare disease sufferers and the quest for FDA approved treatments and therapies.
The Balancing Act is currently looking for: people from pharmaceutical companies doing research, or working on drug therapies for any of the many rare diseases out there; advocates or representatives from various rare disease group; people who are part of the rare disease world to continue with the series and its mission to be a place when people in the rare disease community can gather for more information.
The special airs every few weeks, past specials are available for viewing here: http://www.thebalancingact.com/rare/
If you’d like to get involved, please contact:
Carri Levy
Senior Associate Producer
The Balancing Act
[email protected]
Related Links:
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.